Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Small-molecule inhibitors for the treatment of hepatitis B virus documented in patents.

Geng CA, Wang LJ, Guo RH, Chen JJ.

Mini Rev Med Chem. 2013 Apr 1;13(5):749-76. Review.

PMID:
23317498
2.

Nucleoside analogs as anti-HBV agents.

Zhou XX, Littler E.

Curr Top Med Chem. 2006;6(9):851-65. Review.

PMID:
16787280
3.

Design and development of anti-hepatitis B virus agents.

Kaushik S, Gupta SP, Sharma PK.

Curr Med Chem. 2010;17(29):3377-92. Review.

PMID:
20712567
4.

A review of non-nucleoside anti-hepatitis B virus agents.

Zhang F, Wang G.

Eur J Med Chem. 2014 Mar 21;75:267-81. doi: 10.1016/j.ejmech.2014.01.046. Epub 2014 Jan 30. Review.

PMID:
24549242
5.
6.

Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.

Guo RH, Zhang Q, Ma YB, Luo J, Geng CA, Wang LJ, Zhang XM, Zhou J, Jiang ZY, Chen JJ.

Eur J Med Chem. 2011 Jan;46(1):307-19. doi: 10.1016/j.ejmech.2010.11.019. Epub 2010 Nov 19.

PMID:
21145140
7.

Anti-hepatitis B virus activity of wogonin in vitro and in vivo.

Guo Q, Zhao L, You Q, Yang Y, Gu H, Song G, Lu N, Xin J.

Antiviral Res. 2007 Apr;74(1):16-24. Epub 2007 Jan 24.

PMID:
17280723
8.

Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.

Zhao Z, Hong W, Zeng Z, Wu Y, Hu K, Tian X, Li W, Cao Z.

J Biol Chem. 2012 Aug 31;287(36):30181-90. doi: 10.1074/jbc.M112.370312. Epub 2012 Jul 12.

9.

Management of viral hepatitis B.

Pramoolsinsup C.

J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. Review.

PMID:
12000599
10.

Antiviral activity of FNC, 2'-deoxy-2'-β-fluoro-4'-azidocytidine, against human and duck HBV replication.

Zheng L, Wang Q, Yang X, Guo X, Chen L, Tao L, Dong L, Li Y, An H, Yu X, Wang Q, Chang J.

Antivir Ther. 2012;17(4):679-87. doi: 10.3851/IMP2094. Epub 2012 Mar 27.

PMID:
22452880
11.

Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors.

Zhang Q, Jiang ZY, Luo J, Cheng P, Ma YB, Zhang XM, Zhang FX, Zhou J, Chen JJ.

Bioorg Med Chem Lett. 2008 Aug 15;18(16):4647-50. doi: 10.1016/j.bmcl.2008.07.012. Epub 2008 Jul 10.

PMID:
18644720
12.

Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.

Wang LJ, Geng CA, Ma YB, Huang XY, Luo J, Chen H, Guo RH, Zhang XM, Chen JJ.

Bioorg Med Chem. 2012 May 1;20(9):2877-88. doi: 10.1016/j.bmc.2012.03.023. Epub 2012 Mar 16.

PMID:
22472044
14.

Telbivudine for the management of chronic hepatitis B virus infection.

Matthews SJ.

Clin Ther. 2007 Dec;29(12):2635-53. doi: 10.1016/j.clinthera.2007.12.032. Review.

PMID:
18201580
15.

Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.

Huang TJ, Yang CL, Kuo YC, Chang YC, Yang LM, Chou BH, Lin SJ.

Bioorg Med Chem. 2015 Feb 15;23(4):720-8. doi: 10.1016/j.bmc.2014.12.064. Epub 2015 Jan 2.

PMID:
25600408
16.

Antiviral L-nucleosides specific for hepatitis B virus infection.

Bryant ML, Bridges EG, Placidi L, Faraj A, Loi AG, Pierra C, Dukhan D, Gosselin G, Imbach JL, Hernandez B, Juodawlkis A, Tennant B, Korba B, Cote P, Marion P, Cretton-Scott E, Schinazi RF, Sommadossi JP.

Antimicrob Agents Chemother. 2001 Jan;45(1):229-35.

17.

Hepatitis B virus: old, new and future approaches to antiviral treatment.

Karayiannis P.

J Antimicrob Chemother. 2003 Apr;51(4):761-85. Epub 2003 Mar 13. Review.

PMID:
12654750
18.

Review of small synthetic molecules targeting HBV capsid assembly.

Liu N, Zhao F, Zhan P, Liu X.

Med Chem. 2015;11(8):710-6. Review.

PMID:
25985859
19.

Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.

Kim HJ, Yoo HS, Kim JC, Park CS, Choi MS, Kim M, Choi H, Min JS, Kim YS, Yoon SW, Ahn JK.

J Ethnopharmacol. 2009 Jul 15;124(2):189-96. doi: 10.1016/j.jep.2009.04.046. Epub 2009 May 3.

PMID:
19409970
20.

Henrylactones A-E and anti-HBV constituents from Illicium henryi.

Liu JF, Jiang ZY, Zhang Q, Shi Y, Ma YB, Xie MJ, Zhang XM, Chen JJ.

Planta Med. 2010 Feb;76(2):152-8. doi: 10.1055/s-0029-1186037. Epub 2009 Aug 10.

PMID:
19670158

Supplemental Content

Support Center